Research and Clinical Trials

Brief Description  
Treatment for newly diagnosed Glioblastomas (WHO Grade IV)
Who may be Eligible  

Patients must meet the following inclusion criteria to be eligible to enter the study:

  • Newly diagnosed and resected glioblastoma
  • Diagnosis confirmed by a central lab
  • History & physical and neurological
  • MRI  scans, pre-op, post-op
  • Blood tests (liver, kidney and blood counts) and pregnancy test if indicated
  • Patients with unstable cardiac disease, recent MI, COPD and bleeding disorders are not  eligible
  • age greater or equal to 18 years
  • no previous radiation to the head and scalp
  • no prior invasive malignancy within the past 3 years
IRB Number  
Principal Investigator  
Burri, Stuart

For More Information, Contact  Donna  , C-Johnson
Phone:  (704) 355-1677  Fax:  (704) 355-1188  
Address:Blumenthal Cancer Center 1025 Morehead Medical Drive Suite 600 Charlotte, NC